# A 6-month, Randomized, Double-blind, Placebo Controlled Study Evaluating the Efficacy and Safety of USPlus DERM to Promote Hair Growth in Men and Women With Self-perceived Thinning Hair.

> **NCT06920758** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Ablon Skin Institute Research Center** · enrollment: 60 (actual)

## Conditions studied

- Thinning Hair

## Interventions

- **DIETARY_SUPPLEMENT:** USPlus DERM Bioactive Fatty Acids 160 mg Softgels
- **OTHER:** Placebo softgel

## Key facts

- **NCT ID:** NCT06920758
- **Lead sponsor:** Ablon Skin Institute Research Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-12-16
- **Primary completion:** 2025-09
- **Final completion:** 2025-09
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2025-04-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06920758

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06920758, "A 6-month, Randomized, Double-blind, Placebo Controlled Study Evaluating the Efficacy and Safety of USPlus DERM to Promote Hair Growth in Men and Women With Self-perceived Thinning Hair.". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06920758. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*